Cargando…
Challenging the status flow: how artificial intelligence is advancing diagnosis of myelodysplastic neoplasms
Autores principales: | Duetz, Carolien, Westers, Theresia M., van de Loosdrecht, Arjan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483337/ https://www.ncbi.nlm.nih.gov/pubmed/37078265 http://dx.doi.org/10.3324/haematol.2023.282998 |
Ejemplares similares
-
Computational flow cytometry as a diagnostic tool in suspected‐myelodysplastic syndromes
por: Duetz, Carolien, et al.
Publicado: (2021) -
Dysregulation of developmental and cell type-specific expression of glycoconjugates on hematopoietic cells: a new characteristic of myelodysplastic neoplasms (MDS)
por: van Spronsen, Margot F., et al.
Publicado: (2023) -
Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)‐mutant myelodysplastic syndromes subtype
por: Duetz, Carolien, et al.
Publicado: (2021) -
A series of case studies illustrating the role of flow cytometry in the diagnostic work‐up of myelodysplastic syndromes
por: Westers, Theresia M., et al.
Publicado: (2022) -
Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation
por: van Leeuwen-Kerkhoff, Nathalie, et al.
Publicado: (2020)